L'Oréal Enters Exclusive Partnership for Revolutionary 'Air Only' Fragrance Extraction
L'Oréal has joined forces with Cosmo International Fragrances to gain exclusive access to the fragrance creation company's groundbreaking 'air only' extraction technology.

L’Oréal signs deal for ‘air only’ extracted natural fragrance ingredients
Credit: Cosmetics Business
Cosmo's patent-pending process represents a waterless, energy-efficient extraction technique that unveils the precise aroma of a fragrance while safeguarding its authenticity. This innovative technology captures the volatile fragrance molecules of flowers, fruits, and other natural ingredients without resorting to traditional scent extraction methods involving heating, cooling, or chemical solvents.
According to Cosmo, this approach ensures that natural ingredients maintain their integrity, allowing for recycling and reuse in a subsequent extraction, contributing to waste reduction.
The initial collaboration under this partnership will center on tuberose for an upcoming fine fragrance set for launch in 2024.
Barbara Lavernos, Deputy Chief Executive Officer overseeing Research, Innovation, and Technology at L'Oréal, highlighted how this process enables the company's 100-plus in-house fragrance experts to "experience the olfactive power of flowers authentically, as if strolling through a garden, field, or forest."
Cyril Chapuy, President of L'Oréal Luxe, emphasized the significance of achieving true-to-life scents, describing it as a perfumer's dream. He expressed confidence that, in collaboration with Cosmo International Fragrances, their brands would elevate fine fragrance crafting by providing unparalleled olfactive authenticity, enabling natural ingredients to fully express their unique olfactive identity.
Chapuy further stated, "From ingredient sourcing to refill adoption, we are innovating at every step to reduce our impact and transition toward a more responsible fragrance model."
L'Oréal has a history of partnering with pioneers in beauty ingredient development. In June, the cosmetics giant announced a minority investment by its venture capital fund BOLD (Business Opportunities for L'Oréal Development) in biotech firm Debut, extending existing development plans. Debut specializes in polyphenols, biopolymers, and natural colors through advanced, cell-free biomanufacturing, surpassing the limitations of traditional fermentation processes.
In March, L'Oréal invested in a venture led by Korean biotechnology firm Geno, focusing on sustainable alternatives to key beauty product ingredients. Towards the end of the previous year, BOLD acquired a minority stake in Microphyt, a French biotech firm renowned for pioneering a low-carbon process in microalgae production.
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
L'Oréal to Invest $80 Million in Mexico Factory Expansion
-
L'Oréal's Performance in the First Half of 2025 Was Solid: Growth Across All Business Lines and Continued Improvement in Profit Margins
-
L'Oréal Acquires Professional Hair Care Brand Color Wow
-
L'Oréal May Soon Acquire Medik8 for 1 Billion Euros
-
L'Oréal UK sales hit £1.5 billion
-
L'Oréal's SalonCentric Acquires Concept JP
-
L'Oréal's Quarterly Sales Growth Hit a New Low Since the Epidemic Due to the Weak Chinese Market
-
Sanofi Repurchases 2.3% of L'Oréal Shares
-
L'Oréal acquires Korean skincare brand Dr.G from Swiss conglomerate Migros
-
L'Oréal sells Decléor and Saint-Gervais Mont Blanc to Cospal to streamline portfolio
Recommend Reading
-
Middle East Conflict Exposes Fragility of Global Fertilizer Supply Chains
-
South Korea Retires 1.39 Million Tonnes of Ethylene Capacity as Northeast Asia’s Petrochemical Reset Turns Real
-
"Zipper-Like" Opening and Closing of Hormuz Coupled with Russian Export Ban Send Energy and Chemical Prices Soaring
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
U.S. Fighter Jet Strikes Commercial Cargo Ship in Gulf of Oman, Disabling Propulsion
-
Business Society: Both Supply and Demand Weak, Costs Hard to Sustain—Bisphenol A Set for Volatile Decline in 2025
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
Premium Global Chemical Sourcing Requests (28 Feb - 3 Mar, 2026)
-
In August, the Chinese marine fuel market first declined then rose
-
Business Society’s Market Outlook for Fuel Oil 180CST on September 1, 2026: Volatile